Medicare Enrolled

Dr. Misha Denham, DO

Endocrinology · Coral Gables, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2695 S LE JEUNE RD, Coral Gables, FL 33134
3056728559
Registered in NPPES since 2005
NPI: 1689659096 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Denham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Denham? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Denham

Dr. Misha Denham is an endocrinology specialist in Coral Gables, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Denham performed 865 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Denham received a total of $716,614 from 62 pharmaceutical and/or device companies across 1643 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Denham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 48% volume in FL $716,614 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Osteopathic Physician 9157 Clear March 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
865
Medicare services
Top 48% in FL for endocrinology
Not available
Unique patients (not deduplicated)
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
375 $96 $195
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
113 $3 $10
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
89 $10 $40
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
89 $1 $5
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
78 $29 $90
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
40 $88 $250
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
36 $149 $245
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
33 $86 $185
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
12 $120 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$716,614
Total received (2018-2024)
Avg $102,373/year across 7 years
Top 1% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
1,643
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$86,908
2023
$73,943
2022
$113,793
2021
$92,180
2020
$78,925
2019
$116,833
2018
$154,032

Payments by company (2024)

Lilly USA, LLC
$62,737
Novo Nordisk Inc
$12,365
Mannkind Corporation
$11,209
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
Corcept Therapeutics
$90
AIMMUNE THERAPEUTICS, INC.
$80
ABBVIE INC.
$45
Xeris Pharmaceuticals, Inc.
$43
Verity Pharmaceuticals Inc.
$42
Amneal Pharmaceuticals LLC
$29
Amgen Inc.
$26
Kyowa Kirin, Inc.
$24
Insulet Corporation
$22
Antares Pharma, Inc.
$22
Tandem Diabetes Care, Inc.
$22
Medtronic, Inc.
$22
VIVUS LLC
$21
Neurocrine Biosciences, Inc.
$19
Top 3 companies account for 99.3% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$405,050
Novo Nordisk Inc
$225,875
Merck Sharp & Dohme Corporation
$40,850
Mannkind Corporation
$13,417
MannKind Corporation
$11,747
Janssen Pharmaceuticals, Inc
$11,564
Corcept Therapeutics
$2,549
Boehringer Ingelheim Pharmaceuticals, Inc.
$532
AstraZeneca Pharmaceuticals LP
$444
SANOFI-AVENTIS U.S. LLC
$431
Amgen Inc.
$362
Insulet Corporation
$335
Amarin Pharma Inc.
$315
AbbVie, Inc.
$306
Tandem Diabetes Care, Inc.
$216
Becton, Dickinson and Company
$173
Antares Pharma, Inc.
$170
IBSA Pharma Inc.
$170
Shire North American Group Inc
$129
Amneal Pharmaceuticals LLC
$109
AbbVie Inc.
$108
Currax Pharmaceuticals LLC
$105
Abbott Laboratories
$103
OPKO Pharmaceuticals, LLC
$97
Medtronic MiniMed, Inc.
$92
AIMMUNE THERAPEUTICS, INC.
$80
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$72
CeQur Corporation
$70
EMD Serono, Inc.
$68
Xeris Pharmaceuticals, Inc.
$68
Azurity Pharmaceuticals, Inc.
$67
Medtronic, Inc.
$62
DEXCOM, INC.
$60
ABBVIE INC.
$60
Nestle HealthCare Nutrition Inc.
$52
Kyowa Kirin, Inc.
$48
Bayer HealthCare Pharmaceuticals Inc.
$47
Zealand Pharma US, Inc.
$45
Verity Pharmaceuticals Inc.
$42
Dexcom, Inc.
$39
Gemini Laboratories, LLC
$37
Aytu BioScience, Inc
$32
LIFESCAN, INC.
$31
Radius Health, Inc.
$31
Allergan Inc.
$26
Nalpropion Pharmaceuticals LLC
$26
Embecta Corp.
$23
Senseonics, Incorporated
$23
Novartis Pharmaceuticals Corporation
$22
NESTLE HEALTHCARE NUTRITION INC.
$21
VIVUS LLC
$21
Ascendis Pharma Inc
$20
Alfasigma USA, Inc.
$20
Amryt Pharma Holdings Ltd
$20
Strongbridge US INC.
$19
Neurocrine Biosciences, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$19
Acerus Pharmaceuticals Corporation
$17
Orexigen Therapeutics, Inc.
$17
Acella Pharmaceuticals, LLC
$15
Ultragenyx Pharmaceutical Inc.
$13
Clarus Therapeutics Inc.
$12
Top 3 companies account for 93.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · CONTRAVE · CYCLOSET · CeQur Simplicity · Creon · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUMET · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LINZESS · MACRILEN · MINIMED 780G · MOUNJARO · MYCARELINK · Minimed Paradigm Revel · NATPARA · NOCDURNA · NP Thyroid · Natesto · ONETOUCH VERIO REFLECT · OTREXUP · Omnipod · Ozempic · PANCREAZE · Prolia · RYBELSUS · Rayaldee · Repatha · Rybelsus · SEROSTIM · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYNTHROID · Saxenda · Serostim · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tlando · Tresiba · Tymlos · UBRELVY · UNITHROID · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XIGDUO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · ZEPBOUND · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Coral Gables?
Compare endocrinologists in the Coral Gables area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
121
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
CORAL GABLES HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Denham is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Denham experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Denham performed 375 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Denham receive payments from pharmaceutical companies?
Yes. Dr. Denham received a total of $716,614 from 62 companies across 1,643 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Denham's costs compare to other endocrinologists in Coral Gables?
Dr. Denham's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Denham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →